Markus Steiner

FHI 360 | Senior Epidemiologist & Director, Gates-funded Sino-implant Initiative

Markus J. Steiner, PhD, MSPH, a Senior Epidemiologist, has worked at FHI 360 for the past 30 years focusing on: 1) barrier method acceptability and functionality studies; 2) methods to evaluate validity of self-reported behaviors using bio-markers; 3) contraceptive effectiveness trials; and 4) evaluating approaches of communicating contraceptive effectiveness to clients and providers. He has extensive experience conducting research around the world (Brazil, Cameroon, Chile, China, Ethiopia, Ghana, Hungary, India, Jamaica, Kenya, Ghana, Malawi, Sri Lanka, Thailand, the Dominican Republic, Turkey, and Zimbabwe). He has published over 90 peer-reviewed articles and serves as an ad hoc reviewer for scientific journals including JAMA, American Journal of Public Health, Sexually Transmitted Diseases and Obstetrics & Gynecology. In 2001 he was named adjunct professor in the Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, where he received his PhD in reproductive epidemiology in 1999.

Currently he is leading a $18 million multi-year, Bill & Melinda Gates-funded initiative to provide technical assistance to a manufacturer of a low cost contraceptive implant (Levoplant) that achieved WHO PQ in June 2017. To date this effort has resulted in regulatory approvals in over 20 countries and the distribution of over 1.5 million implants. The estimated public health impact of women using these implants is 1.4 million pregnancies, 3,000 maternal deaths and 175,000 abortions averted, and commodity cost-savings of approximately US$10.5 million. The GMP/GCP/GLP/CMC/distribution experience gleaned from this project is now being applied to other therapeutic areas.